UNSPSC 51162354: Magnesium salicylate/phenyltoloxamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162354 Magnesium salicylate/phenyltoloxamine is a Commodity code that does not align with recent state and local procurement activity. The two most recent opportunities tagged to this code—a Seminole County, Florida purchase of naloxone and drug deactivation systems, and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products—describe naloxone dispensing and broad pharmaceutical procurement respectively, neither of which falls within the scope of magnesium salicylate or phenyltoloxamine products. The code appears to be a nominal classification that does not reflect actual buying patterns in state and local government contracting right now. No relevant solicitations for magnesium salicylate or phenyltoloxamine products were present in the recent-opportunities data.

The mismatch between the code's narrow pharmaceutical composition and the broader health-system procurement being conducted under its label suggests the code sees little to no direct activity in state and local markets, or that tagging practices at issuing bodies do not reliably map these specific compounds. Business development professionals evaluating this code should verify with individual agencies whether magnesium salicylate or phenyltoloxamine products are actually procured through their pharmaceutical or OTC sourcing processes, as the UNSPSC assignment does not currently generate actionable opportunity signals.